NCT02946125 - Study of the Safety, Efficacy and PK of EYN-1601 in Dilation of the Pupil | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions

Mydriasis

Interventions

COMBINATION_PRODUCT

MDD-administered EYN-1601

Phenylephrine hydrochloride ophthalmic solution 10% formulated for microdose spray delivery

DRUG

Phenylephrine 2.5% Eyedrop

Phenylephrine hydrochloride ophthalmic solution 2.5% eyedrop

DRUG

Phenylephrine 10% Eyedrop

Phenylephrine hydrochloride ophthalmic solution 10% eyedrop

Trial Locations (1)

Artesia